{"id":"W4404068475","doi":"10.1021/acsptsci.4c00512","title":"Repurposing Drugs and Synergistic Combinations as Potential Therapies for Inhibiting SARS-CoV-2 and Coronavirus Replication","year":2024,"lang":"en","type":"article","venue":"ACS Pharmacology & Translational Science","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Fonds de Recherche du Québec - Santé; Mitacs; Québec Consortium for Drug Discovery; Institut Pasteur; Institut national de la recherche scientifique; Armand-Frappier Foundation","keywords":"Drug repositioning; Repurposing; Coronavirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Computational biology; Drug; Approved drug; Betacoronavirus; Coronavirus disease 2019 (COVID-19); Pandemic; Favipiravir; Biology; Drug discovery; Nelfinavir; 2019-20 coronavirus outbreak; Virology; Medicine; Pharmacology; Bioinformatics; Virus; Viral load; Infectious disease (medical specialty); Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008799578,0.000108986,0.0001294515,0.0002369045,0.0005072711,0.0001142377,0.0001030651,0.00005867827,0.000004970989],"category_scores_gemma":[0.00008722862,0.0001011286,0.00003542271,0.0004610566,0.0008918034,0.0003535704,0.00003239536,0.0001729269,0.000005571853],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005886418,"about_ca_system_score_gemma":0.0004683294,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004489068,"about_ca_topic_score_gemma":0.000004145317,"domain_scores_codex":[0.9985874,0.00003445421,0.0002150273,0.0005404245,0.0003583151,0.0002643735],"domain_scores_gemma":[0.9992123,0.000410782,0.00003701495,0.0001002573,0.0002044169,0.00003527896],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009727976,0.00005130328,0.000473901,0.00006598516,0.00003372636,0.00001187078,0.0008111527,0.000001839847,0.9511983,0.009296128,0.00006626712,0.03789218],"study_design_scores_gemma":[0.001740285,0.0002083831,0.003662038,0.00007114661,0.0001780183,0.0001843089,0.0001157865,0.02792521,0.9369689,0.01126053,0.01751946,0.0001659497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9870013,0.003556454,0.002550013,0.005357479,0.0001963045,0.0006330037,0.00001644065,0.00007966219,0.0006093553],"genre_scores_gemma":[0.9897207,0.00004157869,0.0006582148,0.009315231,0.000116245,0.0001093055,0.000008514485,0.00001258324,0.00001763102],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03772623,"threshold_uncertainty_score":0.4123904,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05843524321598349,"score_gpt":0.4281452466231933,"score_spread":0.3697100034072098,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}